4887 logo

Sawai Group Holdings Co., Ltd. Stock Price

TSE:4887 Community·JP¥221.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

4887 Share Price Performance

JP¥1,919.00
-103.00 (-5.09%)
JP¥1,919.00
-103.00 (-5.09%)
Price JP¥1,919.00

4887 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Average dividend payer and fair value.

3 Risks
2 Rewards

Sawai Group Holdings Co., Ltd. Key Details

JP¥194.2b

Revenue

JP¥136.4b

Cost of Revenue

JP¥57.8b

Gross Profit

JP¥43.8b

Other Expenses

JP¥13.9b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 14, 2025
120.76
29.75%
7.18%
60.0%
View Full Analysis

About 4887

Founded
1929
Employees
3310
CEO
Mitsuo Sawai
WebsiteView website
www.sawaigroup.holdings

Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the research and development, manufacture, and marketing of generic pharmaceuticals. The company offers generic drugs in various dosage forms, including tablets, oral dispersing tablets, capsules, granules, injectables, tapes, ophthalmic or nasal solutions, syrups, and other forms for various therapeutic areas comprising cardiovascular, gastro-intestinal, blood/body fluid, other metabolic, antibiotics, central nervous system, antiallergics, anti-cancer, urogenital organs and anus, chemotherapeutic and antineoplastic agents, respiratory system, etc., as well as vitamin preparations. It sells its generic drugs through distributors, wholesalers, and retailers in Japan and the United States. The company was founded in 1929 and is headquartered in Osaka, Japan.

Recent 4887 News & Updates

Here's Why Sawai Group Holdings (TSE:4887) Has A Meaningful Debt Burden

Oct 01
Here's Why Sawai Group Holdings (TSE:4887) Has A Meaningful Debt Burden

Recent updates

No updates